Viewing Study NCT05654532


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-18 @ 2:10 PM
Study NCT ID: NCT05654532
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-30
First Post: 2022-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer
Sponsor: Accutar Biotechnology Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module